Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick G Hayden

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Influenza and Other Respiratory Viruses|November 13, 2013
Advances in antivirals for non-influenza respiratory virus infectionsFrederick G Hayden
The New England Journal of Medicine|February 24, 2006
Antiviral resistance in influenza viruses--implications for management and pandemic responseFrederick G Hayden
Antiviral Therapy|February 8, 2012
Experimental human influenza: observations from studies of influenza antiviralsFrederick G Hayden
Current Opinion in Infectious Diseases|March 4, 2006
Respiratory viral threatsFrederick G Hayden
Influenza and Other Respiratory Viruses|January 3, 2013
Newer influenza antivirals, biotherapeutics and combinationsFrederick G Hayden
Reviews in Medical Virology|January 13, 2004
Rhinovirus and the lower respiratory tractFrederick G Hayden
The Pediatric Infectious Disease Journal|December 4, 2004
Pandemic influenza: is an antiviral response realistic?Frederick G Hayden
Antiviral Research|July 4, 2006
Antivirals for influenza: historical perspectives and lessons learnedFrederick G Hayden
JAMA|December 18, 2025
Influenza A(H3N2) Subclade K Virus: Threat and ResponseMaria Zambon, Frederick G Hayden
Lancet (London, England)|October 8, 2020
Antiviral monotherapy for hospitalised patients with COVID-19 is not enoughBin Cao, Frederick G Hayden
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Influenza and Other Respiratory Viruses|November 13, 2013
Advances in antivirals for non-influenza respiratory virus infectionsFrederick G Hayden
The New England Journal of Medicine|February 24, 2006
Antiviral resistance in influenza viruses--implications for management and pandemic responseFrederick G Hayden
Antiviral Therapy|February 8, 2012
Experimental human influenza: observations from studies of influenza antiviralsFrederick G Hayden
Current Opinion in Infectious Diseases|March 4, 2006
Respiratory viral threatsFrederick G Hayden
Influenza and Other Respiratory Viruses|January 3, 2013
Newer influenza antivirals, biotherapeutics and combinationsFrederick G Hayden
Reviews in Medical Virology|January 13, 2004
Rhinovirus and the lower respiratory tractFrederick G Hayden
The Pediatric Infectious Disease Journal|December 4, 2004
Pandemic influenza: is an antiviral response realistic?Frederick G Hayden
Antiviral Research|July 4, 2006
Antivirals for influenza: historical perspectives and lessons learnedFrederick G Hayden
JAMA|December 18, 2025
Influenza A(H3N2) Subclade K Virus: Threat and ResponseMaria Zambon, Frederick G Hayden
Lancet (London, England)|October 8, 2020
Antiviral monotherapy for hospitalised patients with COVID-19 is not enoughBin Cao, Frederick G Hayden
Pageof 16